HOME
FAQs
BLOG
SUBMIT LISTING/OFFER
EXPERTS DIRECTORY
✕
Filter by
Categories
Tags
Authors
Show all
All
Patents
All
505(b)(2)
alternative path
board of directors
Business strategy
cdc
CDC impact
CEO
Clinical Trials
CMS
deadlines
escrow
extending a patent
FDA
FDA Approval
financial impact
Grants
history
Hold
institutional path
invention
IRS
Juggling
License
Marketing
Medicaid
medical patent
Medicare
orphan drugs
Patent
Patent Maestro
Patent Strategy
patents
phase III
Phase IV
problems
Process
Remaining Patent Term
risk management
ROI
Sell
stock split
stocks
Strategy
tax
time
Timing
Transfers
All
admin
Kenneth Pearce
August 3, 2026
Waylaid in Phase III: What to Do When the FDA Panel Questions Your Foundation
April 29, 2026
The Trifecta Medical Patent Transfer: All Three Have To Match For A Win